Results 11 to 20 of about 13,962,328 (182)

Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with Brucella abortus, B. melitensis and B. suis

EFSA Journal, 2017
The infection with Brucella abortus, Brucella melitensis and Brucella suis has been assessed according to the criteria of the Animal Health Law (AHL), in particular criteria of Article 7 on disease profile and impacts, Article 5 on the eligibility of the
EFSA Panel on Animal Health and Welfare (AHAW), Simon More, Anette Bøtner, Andrew Butterworth, Paolo Calistri, Klaus Depner, Sandra Edwards, Bruno Garin‐Bastuji, Margaret Good, Christian Gortázar Schmidt, Virginie Michel, Miguel Angel Miranda, Søren Saxmose Nielsen, Mohan Raj, Liisa Sihvonen, Hans Spoolder, Jan Arend Stegeman, Hans‐Hermann Thulke, Antonio Velarde, Preben Willeberg, Christoph Winckler, Francesca Baldinelli, Alessandro Broglia, Frank Verdonck, Beatriz Beltrán Beck, Lisa Kohnle, Joana Morgado, Dominique Bicout   +27 more
doaj   +2 more sources

B. Melitensis and B. Abortus Agglutinins in Dispensary Patients.

Experimental Biology and Medicine, 1927
Sera obtained from routine Wassermann test were tested for agglutinins, for B. melitensis and B. abortus in the average outdoor dispensary population in Chicago. Brucella melitensis variety Melitensis (A) No. 428, and variety abortus No. 456 were sent to us by Alice C. Evans and were used as our antigen.
L. Arnold, W. E. Miller
openaire   +2 more sources

Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis [PDF]

Vaccine, 2012
Because of the serious economic and medical consequences of brucellosis, efforts are to prevent infection of domestic animals through vaccines. Many disadvantages are associated with the current Brucella melitensis Rev.1 vaccine prompting development of alternative vaccines and delivery.
V K, Gupta, G, Radhakrishnan, J, Harms, G, Splitter   +3 more
openaire   +3 more sources

Nondividing but Metabolically Active Gamma-IrradiatedBrucella melitensisIs Protective against VirulentB. melitensisChallenge in Mice [PDF]

Infection and Immunity, 2009
ABSTRACTBrucellaspp. are gram-negative bacteria that cause the most frequent zoonotic disease worldwide, with more than 500,000 human infections yearly; however, no human vaccine is currently available. As with other intracellular organisms, cytotoxic mechanisms against infected cells are thought to have an important role in controlling infection and ...
D M, Magnani, J S, Harms, M A, Durward, G A, Splitter   +3 more
openaire   +3 more sources

Real-Time Multiplex PCR Assay for Detection of Brucella spp., B. abortus , and B. melitensis [PDF]

Journal of Clinical Microbiology, 2004
ABSTRACT The identification of Brucella can be a time-consuming and labor-intensive process that places personnel at risk for laboratory-acquired infection. Here, we describe a real-time PCR assay for confirmation of presumptive Brucella isolates.
William S, Probert, Kimmi N, Schrader, Nhi Y, Khuong, Susan L, Bystrom, Margot H, Graves   +4 more
openaire   +3 more sources

Rapid Multiplex PCR Assay for the Simultaneous Detection of the Brucella Genus, B. abortus, B. melitensis, and B. suis

Journal of Microbiology and Biotechnology, 2011
The routine identification and differentiation of Brucella species is a time-consuming and labor-intensive process, which frequently places personnel at risk of laboratoryacquired infection. Here, we describe the development of a rapid multiplex PCR assay for the confirmation of presumptive Brucella isolates.
Sanjay, Kumar, Urmil, Tuteja, Kumari, Sarika, Dhirendra, Singh, Ashok, Kumar, Om, Kumar   +5 more
openaire   +3 more sources

Effect of antibiotics contained in two Brucella selective media on growth of Brucella abortus, B. melitensis, and B. ovis [PDF]

Journal of Clinical Microbiology, 1996
The MIC and the highest concentration enabling bacterial growth (CEG) of the antibiotics contained in two selective media were determined for Brucella abortus, B. melitensis, and B. ovis. The nalidixic acid and bacitracin contained in Farrell's selective medium were responsible for the inhibitory effects observed.
C M, Marín, J L, Alabart, J M, Blasco
openaire   +3 more sources

Enzyme-linked immunosorbent assay with partially purified cytosoluble 28-kilodalton protein for serological differentiation between Brucella melitensis-infected and B. melitensis Rev.1-vaccinated sheep [PDF]

Clinical Diagnostic Laboratory Immunology, 1996
The problem of differentiating sheep infected with Brucella melitensis from those vaccinated or exposed to cross-reaching organisms has not been resolved by conventional serological tests or through the use of the smooth lipopolysaccharide in primary binding assays. We therefore analyzed sera from ewes experimentally infected with B.
H, Salih-Alj Debbarh, A, Cloeckaert, G, Bézard, G, Dubray, M S, Zygmunt   +4 more
openaire   +3 more sources

ON THE SEROLOGICAL DIFFERENTIATION OF B. ABORTUS AND B. MELITENSIS

Journal of The Japanese Society of Veterinary Science, 1924
H. Futamura
openaire   +3 more sources

<i>Brucella</i>'s Emerging Threat: A Global Systematic Review and Meta-Analysis Revealing Temporal, Geographic and Species-Specific Patterns of Antimicrobial Resistance. [PDF]

Vet Med Int
Antimicrobial resistance (AMR) can lead to treatment failure in human bacterial infections, resulting in increased morbidity and mortality. Brucellosis is a globally significant zoonotic infection caused by Brucella spp. bacteria, yet the frequency and extent of AMR in Brucella populations from humans are poorly characterised.
Tut G.
europepmc   +2 more sources